IPOGrid
0001509261
IPO filing research

Rezolute, Inc.

Pharmaceutical Preparations · RZLT

follow-on trading filed Nasdaq DRS

Rezolute, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: DRS on 2026-10-15. Current deal snapshot: exchange Nasdaq.

Filing Timeline

SEC EDGAR
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after EFFECT.
2026-10-15 · 0001104659-26-116249
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2025-08-08 · 9999999995-25-002534
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $3.25 · 20,786,923 shares · Gross proceeds $89,993,096
Common Stock · Exchange Nasdaq · Ticker RZLT · Over-allotment 4,153,846 · Pre-Funded Warrants to purchase up to 6,905,385 shares of common stock · Underwriters Guggenheim Securities, BTIG, H.C. Wainwright & Co.
2025-04-23 · 0001104659-25-038091
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Common Stock; Pre-Funded Warrants to Purchase Common Stock · Exchange Nasdaq · Ticker RZLT · Pre-Funded Warrants with $0.001 exercise price · Underwriters Guggenheim Securities, LLC
2025-04-23 · 0001104659-25-038086
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2024-08-14 · 9999999995-24-002531
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $4.00 · 11,250,000 shares · Gross proceeds $59,996,250
Common Stock · Exchange Nasdaq · Ticker RZLT · Over-allotment 2,250,000 · 3,750,000 Pre-Funded Warrants to purchase shares of Common Stock with exercise price $0.001 · Use of proceeds General corporate purposes · Underwriters Jefferies Cantor, BTIG, Craig-Hallum
2024-06-14 · 0001104659-24-071811
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Common Stock · Exchange Nasdaq · Ticker RZLT · Pre-Funded Warrants to purchase shares of common stock with $0.001 exercise price · Use of proceeds working capital · Underwriters Jefferies Cantor
2024-06-13 · 0001104659-24-071356
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-11-29 · 9999999995-23-003491
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-11-09 · 9999999995-22-003247
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-07-01 · 9999999995-22-001956
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
10,947,371 shares · Gross proceeds $10,000
CLASS_B · Exchange NASDAQ · Ticker RZLT · Class B Warrants exercisable at $0.001 per share · Selling stockholders only · Use of proceeds General corporate purposes · Flags warrants · Underwriters Jefferies LLC
2022-07-01 · 0001104659-22-076915
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
138,388 shares
Common Stock · Underwriters Oppenheimer & Co. Inc.
2022-05-20 · 0001104659-22-063358
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
149,507 shares
Shares of Common Stock · Underwriters Lincoln Park Capital Fund, LLC
2022-05-20 · 0001104659-22-063355
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2022-05-02 · 0001104659-22-053992
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $6.50 · 769,231 shares · Gross proceeds $5,000,000
Common Stock · Exchange NASDAQ · Ticker RZLT
2021-10-14 · 0001104659-21-126230
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2021-10-14 · 0001104659-21-126214
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Shares of Common Stock · Exchange Nasdaq · Ticker RZLT · Pre-funded warrants exercisable for one share of common stock · Use of proceeds to fund clinical research and development and for working capital and general corporate purposes · Flags warrants
2021-10-12 · 0001104659-21-125307
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $11.10 · 1,801,802 shares · Gross proceeds $20,000,000
common · Exchange Nasdaq · Ticker RZLT · Use of proceeds general corporate purposes · Underwriters Lincoln Park Capital Fund, LLC
2021-08-04 · 0001104659-21-099589
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-24 · 9999999995-21-002482
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002454
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002451
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002450
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002449
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002447
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002446
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002445
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-23 · 9999999995-21-002444
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-01-06 · 9999999995-21-000048
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
2020-11-27 · 9999999995-20-003326
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2020-11-09 · 0001354457-20-000671
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows EFFECT and registers the class of securities for exchange listing.
2020-11-04 · 0001104659-20-121068
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2019-12-06 · 9999999995-19-002754
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
9,246,857 shares
Common Stock · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds Proceeds go to selling stockholders with no issuer proceeds
2019-12-06 · 0001104659-19-070617
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Price $0.11 · 9,246,857 shares · Gross proceeds $1,024,552
Common · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds Proceeds go to selling stockholders; company does not receive any proceeds
2019-11-18 · 0001104659-19-065134
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
244,346,914 shares
Common Stock · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds Proceeds from the exercise of Bridge Warrants
2019-09-19 · 0001144204-19-045124
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2019-09-18 · 9999999995-19-002120
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
231,454,572 shares
Common stock, par value $0.001 · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds · Flags self_underwritten
2019-09-10 · 0001144204-19-043985
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Common stock, par value · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds Selling stockholders will receive proceeds, issuer does not
2019-08-19 · 0001144204-19-040453
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Price $0.21 · 231,454,572 shares · Gross proceeds $48,605,460
Common · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds Selling stockholders will receive the proceeds from the sale of the common stock
2019-08-15 · 0001144204-19-040290
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
13,095,063 shares · Gross proceeds $10,000,000
Common Stock · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds Proceeds from the offering will be used for general corporate purposes. · Underwriters Lincoln Park Capital Fund, LLC, unaffiliated broker-dealer
2018-02-15 · 0001144204-18-009234
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2018-02-13 · 9999999995-18-000434
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Price $0.90 · 13,095,063 shares · Gross proceeds $11,785,557
Common Stock, par value $0.001 · Exchange OTCQB · Ticker RZLT · Selling stockholders only · Use of proceeds Proceeds to the company are up to $10 million for general corporate purposes · Underwriters Lincoln Park Capital Fund, LLC, unaffiliated broker-dealer
2018-01-29 · 0001144204-18-004365
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
5,100,000 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Selling stockholders only · Use of proceeds We will not receive any of the proceeds from the resale or other disposition of the shares of our common stock covered by this prospectus by the selling stockholders
2017-11-09 · 0001144204-17-057566
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2017-11-08 · 9999999995-17-002914
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Common Stock, $0.001 to be offered for resale by the selling stockholders · Selling stockholders only · Use of proceeds Selling stockholders reselling shares; no issuer proceeds
2017-11-07 · 0001144204-17-056695
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
common stock, $0.001 par value · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds
2017-10-31 · 0001144204-17-055224
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Common · Selling stockholders only · Use of proceeds Selling stockholders will receive proceeds, issuer does not
2017-09-22 · 0001144204-17-049275
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
30,215,200 shares
Common Stock · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes · Flags units, warrants
2017-01-20 · 0001144204-17-003032
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2017-01-19 · 9999999995-17-000163
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $1.39 · Range $1.39 to $1.65 · 16,950,057 shares · Gross proceeds $0.00
Common stock, $0.001 · Ticker REZL · Units and Warrants · Warrants issued in connection with Unit Financing · Selling stockholders only · Use of proceeds Selling stockholders resell shares; no proceeds to the issuer
2017-01-13 · 0001144204-17-002209
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
16,950,057 shares
Common Stock · Warrants issued in connection with Unit Financings · Selling stockholders only · Use of proceeds Selling stockholders reselling shares; issuer receives no proceeds
2016-12-08 · 0001144204-16-138558
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
13,906,331 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Unit Warrants and compensation warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises
2016-11-07 · 0001144204-16-132018
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
14,958,633 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Warrants issued in connection with Bridge and Unit Financings · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds
2016-11-07 · 0001144204-16-132015
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2016-10-24 · 9999999995-16-006054
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2016-10-24 · 9999999995-16-006052
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
13,906,331 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Warrants issued to selling stockholders in connection with the Unit Financing · Selling stockholders only · Use of proceeds Proceeds will be received by the selling stockholders, not the company.
2016-05-17 · 0001144204-16-102985
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
14,958,633 shares · Gross proceeds $0.00
Common Stock · Warrants issued in connection with Bridge and Unit Financings · Selling stockholders only · Use of proceeds Proceeds from warrant exercises used for general corporate purposes
2016-05-17 · 0001144204-16-102983
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
13,906,331 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Placement Agent issued warrants to purchase 120,385 shares at $2.34 · Selling stockholders only · Use of proceeds Proceeds from warrant exercises · Flags warrants · Underwriters Placement Agent
2016-03-15 · 0000912282-16-000644
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-03-15 · 0000912282-16-000643
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
13,906,331 shares
Common · Exchange OTCQB · Ticker ANTB · Each unit consists of one share of common stock and one common share purchase warrant · Warrants to purchase one share of common stock at $2.50 per share, expiring 36 months from issuance · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes · Flags units, warrants
2016-02-16 · 0001144204-16-082186
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
14,958,633 shares
share of our common stock and one common share · Includes Bridge Warrants, Unit Warrants, Bridge Incentive Warrants, and compensation warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises used for general corporate purposes
2016-02-16 · 0001144204-16-082184
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
13,906,331 shares · Gross proceeds $0.00
Common Stock · Exchange OTCQB · Ticker ANTB · Units issued in the Unit Financing · Unit Warrants issued to selling stockholders; compensation warrants issued to selling stockholders · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes
2015-12-17 · 0000912282-15-000462
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
14,958,633 shares
Common Stock · Warrants to purchase common stock issued in connection with Bridge and Unit Financings · Selling stockholders only · Use of proceeds Proceeds from warrant exercises · Flags units, warrants
2015-12-17 · 0000912282-15-000460
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
13,906,331 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Units · Unit Warrants and compensation warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises · Flags units
2015-11-16 · 0001144204-15-065765
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
14,958,633 shares
Common Stock · Unit Financing · Includes Bridge Warrants, Unit Warrants, Bridge Incentive Warrants, and compensation warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises used for general corporate purposes
2015-11-16 · 0001144204-15-065762
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
14,958,633 shares · Gross proceeds $0.00
Common · Exchange OTCQB · Ticker ANTB · Includes warrants from Bridge Financing, Unit Financing, and incentive compensation · Selling stockholders only · Use of proceeds Selling stockholders will receive proceeds from the resale; company does not receive any
2015-10-27 · 0001144204-15-060937
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
13,906,331 shares
Exchange OTCQB · Ticker ANTB · Unit Warrants and compensation warrants · Selling stockholders only · Use of proceeds No proceeds to the issuer; proceeds from warrant exercises · Flags warrants
2015-10-27 · 0001144204-15-060935
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2015-10-22 · 9999999995-15-002835
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2015-10-22 · 9999999995-15-002830
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
13,906,331 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Unit Warrants and compensation warrants issued to selling stockholders · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes · Flags units, warrants
2015-08-04 · 0001144204-15-046091
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2015-07-29 · 9999999995-15-002097
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $1.58 · Range $1.58 to $1.58 · 6,040,921 shares · Gross proceeds $9,544,655
Common Stock · Unit Financings · Warrants to purchase shares · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds · Flags units, warrants
2015-07-22 · 0001144204-15-043643
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior 424B3 filing.
Price $1.58 · 6,040,921 shares · Gross proceeds $9,544,655
Common stock offered for resale by selling stockholders · Units · Warrants to purchase additional shares at 135% and 150% of the conversion price · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds · Flags units, warrants
2015-07-07 · 0001144204-15-041325
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
14,958,633 shares
Common Stock · Warrants to purchase common stock issued in connection with Bridge and Unit Financings · Selling stockholders only · Use of proceeds Proceeds from warrant exercises
2015-06-01 · 0001144204-15-034717
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Price $1.58 · 6,040,921 shares
Common Stock · Warrants to purchase additional shares at 135% and 150% of the conversion price. · Selling stockholders only · Use of proceeds Proceeds go to selling stockholders; no issuer proceeds. · Flags units, warrants
2015-05-22 · 0001144204-15-033271
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
14,958,633 shares
Common · Includes Bridge Warrants, Unit Warrants, Bridge Incentive Warrants, and compensation warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes
2015-03-04 · 0001144204-15-013769
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
14,958,633 shares
Common Stock · Warrants issued in connection with Bridge and Unit Financings · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds
2014-11-26 · 0001144204-14-071205
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
14,958,633 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Includes Bridge Warrants, Unit Warrants, and other incentive warrants · Selling stockholders only · Use of proceeds To receive cash exercise prices from warrant holders · Flags units
2014-10-24 · 0001144204-14-062771
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2014-10-23 · 9999999995-14-003124
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
14,958,633 shares
Common Stock · Exchange OTCQB · Ticker ANTB · Warrants issued in connection with Bridge and Unit Financings · Selling stockholders only · Use of proceeds Company will receive cash from warrant exercises but will not receive proceeds from resale of shares
2014-07-03 · 0001144204-14-041346
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2014-07-01 · 9999999995-14-002001
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $1.85 · 2,412,106 shares · Gross proceeds $4,045,667
Common · Warrants to purchase shares at 135% of conversion price · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds · Flags warrants
2014-06-25 · 0001144204-14-039552
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
Price $1.85 · 2,412,106 shares · Gross proceeds $4,462,396
Common Stock · Warrants to purchase common stock at 135% and 150% of the conversion price · Selling stockholders only · Use of proceeds Selling stockholders will receive proceeds from the sale of shares; no proceeds to the company · Flags warrants
2014-05-20 · 0001144204-14-032197
RW withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows S-1/A and ends the active registration process.
2013-12-19 · 0000912282-13-000667
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Gross proceeds $12,000,000
Series A Convertible Preferred Stock and Warrants · Units consisting of Series A Convertible Preferred Stock and Warrants · Warrants to purchase common stock · Use of proceeds Lease lab facility, perform improvements, and fund clinical trials · Flags units, warrants · Underwriters Ladenburg Thalmann & Co., Inc.
2013-11-14 · 0001144204-13-061142
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Gross proceeds $12,000,000
Series A Convertible Preferred Stock and Warrants · Units consisting of Series A Convertible Preferred Stock and Warrants · Warrants to purchase common stock · Use of proceeds Lease a lab facility and perform leasehold improvements, advance clinical trials, and obtain regulatory approvals · Flags units, warrants · Underwriters Ladenburg Thalmann & Co., Inc.
2013-09-30 · 0001144204-13-053071
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $0.05 · 786,000 shares · Gross proceeds $39,300
Common Stock · Exchange OTC Bulletin Board · Ticker FMYY.OB · Selling stockholders only · Use of proceeds Proceeds will go to selling stockholders; no proceeds to the issuer
2012-05-16 · 0001144204-12-030013
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $0.05 · 786,000 shares · Gross proceeds $39,300
Common Stock · Exchange OTC · Selling stockholders only · Use of proceeds To pay the expenses of this offering · Flags foreign_private_issuer
2012-02-16 · 0001144204-12-009635
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $0.05 · 786,000 shares · Gross proceeds $0.00
Common Stock · Exchange OTC · Selling stockholders only · Use of proceeds Proceeds go to selling stockholders; company does not receive any proceeds
2011-11-15 · 0001144204-11-065139
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Price $0.05 · 786,000 shares
Common Stock · Exchange OTC · Selling stockholders only · Use of proceeds Selling stockholders are offering shares, and the company will not receive any proceeds.
2011-09-28 · 0001144204-11-055177
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2011-08-15 · 0001144204-11-046948
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2011-08-12 · 9999999995-11-002484
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $0.05 · 786,000 shares · Gross proceeds $39,300
Common Stock · Selling stockholders only · Use of proceeds Selling stockholders will receive proceeds from the sale of shares
2011-08-11 · 0001144204-11-045521
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $0.05 · 786,000 shares · Gross proceeds $39,300
or more of the following methods when selling share · Exchange OTC · Selling stockholders only · Use of proceeds Proceeds will be used for general corporate purposes by the selling stockholders
2011-08-08 · 0001144204-11-044552
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $0.05 · 786,000 shares · Gross proceeds $39,300
Common Stock · Selling stockholders only · Use of proceeds Proceeds will go to selling stockholders with no issuer proceeds
Rezolute, Inc. is a development-stage company with no revenue, facing significant risks including its ability to continue as a going concern, reliance on management, and uncertainty in product development. The company has incurred losses since inception and requires substantial capital to fund operations, with no assurance of future profitability. Key risks include dependence on a single technology provider, lack of intellectual property protection, and potential market acceptance challenges.
2011-07-20 · 0001144204-11-041263
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Price $0.05 · Range $0.05 to $0.05 · 786,000 shares · Gross proceeds $39,300
or more of the following methods when selling share · Selling stockholders only · Use of proceeds Proceeds will go to selling stockholders with no issuer proceeds
Rezolute, Inc. is a development-stage company with no revenue, expecting losses for the next 12 months. It faces significant risks including reliance on a single officer, capital requirements, technology dependency, and market acceptance uncertainties. Auditors issued a going concern opinion due to financial challenges.
2011-06-14 · 0001144204-11-035759
Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+12.0%
Median day-1
60%
Above issue
+12.8%
Median week-1
-12.3%
Downside (p10)
Aspen Neuroscience, Inc. ASPE
2026-10-30 $141M Day 1: -0.7% Wk 1: -21.6%
same SICrecent IPO
CITY THERAPEUTICS, INC. CTY
2026-10-16 $200M Day 1: +23.0% Wk 1: +15.4%
same SICrecent IPO
Retension Pharmaceuticals, Inc. RTSN
2026-10-09 $45M Day 1: -12.3% Wk 1: +1.8%
same SICrecent IPO
ADARx Pharmaceuticals, Inc. ADRX
2026-09-25 $446M Day 1: +13.8% Wk 1: +14.1%
same SICrecent IPO
Vogenx, Inc. VOGX
2026-08-12 $81M Day 1: +0.0% Wk 1: +51.9%
same SICrecent IPO
BlossomHill Therapeutics, Inc. BLSM
2026-08-07 $150M Day 1: +0.0% Wk 1: +2.2%
same SICrecent IPO
Latigo Biotherapeutics, Inc. LTGO
2026-08-07 $346M Day 1: +1.4% Wk 1: +11.4%
same SICrecent IPO
Braveheart Bio, Inc. BRVE
2026-08-06 $383M Day 1: +65.6% Wk 1: +45.3%
same SICrecent IPO

Recent News

No recent news stored for this issuer.